Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, explains how breast magnetic resonance imaging (MRI) can be used to clearly identify breast cancers in women with dense breast tissue. In women with dense breasts, it can be very difficult to detect many cancers on standard mammograms because the cancers and dense tissue both appear white. MRI can help clearly define tumors and identify which nodules are cancer and which are benign, which can help greatly reduce the need for biopsies.

Kuhl is an expert in breast imaging and breast MRI. She helped develop an a shortened MRI protocol that allows breast MR images to be created in 3 minutes or less, rather than standard protocols that can take up to 30 minutes. In the interview she shows patient case examples of standard mammograms and the MRI supplemental imaging for the same patient to show the hidden tumors. 

She also explains the differences between standard 2-d mammography, the current standard of care, and the newer 3-D mammogram tomosythnesis technology, breast ultrasound and breast MRI technologies.

Other video interviews with Dr. Kuhl:

VIDEO: Explaining Dense Breasts

VIDEO: The Impact of COVID-19 on Breast Imaging

Related Breast MRI Content:

Abbreviated MRI Outperforms 3-D Mammograms at Finding Cancer in Dense Breasts

VIDEO: Explaining Dense Breasts — Interview with Christiane Kuhl, M.D.

VIDEO: Use of Breast MRI Improved Cancer Detection in Dense Breasts in Dutch Study — Interview with Gillian Newstead, M.D.

Technologies to Watch in Breast Imaging

Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients

Rapid Breast MRI Screening Improves Cancer Detection in Dense Breasts

Breast MRI in Cancer Diagnosis
 

Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, explains what it means to have dense breasts and how density can hide cancers in mammograms. She offers an explanation describing dense breast tissue and that this occurs in about half of women. Density is itself a risk factor for breast cancer and the fact that dense tissue hides cancers on mammography means that supplemental imaging is needed to accurately diagnose these patients and avoid false positives, or needless tissue biopsies. Breast ultrasound and breast magnetic resonance imaging (MRI) can be used to see through dense tissue to better identify cancers and avoid the need for many biopsies.

Other video interviews with Dr. Kuhl:

VIDEO: Use of Breast MRI Screening in Women With Dense Breasts

VIDEO: The Impact of COVID-19 on Breast Imaging

Related Dense Breast Content:

Breast Density Explained

Animation to Bring Clarity to Dense Breasts

Improving Clinical Image Quality for Breast Imaging

Breast Imaging in the Age of Coronavirus

Abbreviated MRI Outperforms 3-D Mammograms at Finding Cancer in Dense Breasts

VIDEO: Use of Breast MRI Improved Cancer Detection in Dense Breasts in Dutch Study — Interview with Gillian Newstead, M.D.

Technologies to Watch in Breast Imaging

Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients

Imaging Technology News Contributing Editor Greg Freiherr interviewed Henry Izawa, vice president of modality solutions, Fujifilm Medical Systems U.S.A., Inc. about Fujifilm's latest innovations in mammography.

In this video, Izawa announces the latest imaging advancements available for the Aspire Cristalle digital mammography system with digital breast tomosynthesis, including S-View, a synthesized 2-D image reconstructed from DBT and other patient enhancements such as the comfort paddle to provide a noticeably more comfortable exam for the patient.

Watch the video to hear all about Fujifilm's updates.

To learn more, visit www.fujimed.com

Karen Ordovas, M.D., MAS, professor of radiology and cardiology at the University of California San Francisco (UCFS) School of Medicine and a Society of Cardiac Magnetic Resonance (SCMR) board member, explains how cardiac MRI can help in women's heart disease and to better define complex congenital heart anatomy. She spoke at the 2019 Radiological Society of North America (RSNA) meeting. 

She specializes in cardiac and pulmonary imaging, and has particular expertise in using CT and MRI techniques in cardiovascular imaging and the differences of presentation in imaging between male and female cardiac patients. Ordovas is helping advance education around heart disease in women and bring great awareness of quality tools to diagnose heart disease and how heart MRI can help. She also is heavily involved in the use of heart MRIs for pregnant women, since there is no radiation,  and patients with congenital heart disease where detailed imaging of the complex anatomy is required.

The use of cardiac MRI in congenital heart disease is common in serial imaging of patients with Tetralogy of Fallot (TOF), one of the most common congenital heart diseases for which patients are referred for post-operative magnetic resonance (MR) imaging evaluation. In the past few decades, surgery has proved successful, but most patients require repeat imaging throughout their lives and MRI can offer more detailed soft tissue imaging without the use of radiation. 

Related Cardiac MRI Content:

VIDEO: Advances in Cardiac MRI Technology — Interview with James Carr, M.D.

Cardiac MRI Delivers Accurate Diagnosis for Frontline Chest Pain Evaluation

VIDEO: Dedicated Cardiac MRI Use at the Baylor Scott White Heart Hospital

Advantages and New Applications of Cardiac MRI

Will Cardiac MRI Expand?

Gillian Newstead, M.D., director of global breast imaging and former professor at the University of Chicago, explains a large breast MRI screening study presented at the 2019 Radiological Society of North America (RSNA) meeting. 

The DENSE Trial Study Group included 40,000 women from the Netherlands who underwent standard mammography. Of these, 8,061 women were identified as having dense breasts and were offered supplemental MRI screening, and about half took advantage of the additional screening. Dense breast tissue which can obscure cancer on conventional mammograms but not on MRI. The MRI cancer-detection rate among the women who actually underwent MRI screening was 16.5 per 1,000 screenings.

The use of supplemental magnetic resonance imaging (MRI) screening in women with extremely dense breast tissue and normal results on mammography resulted in the diagnosis of significantly fewer interval cancers than mammography alone during a two-year screening period. The results were published in the Nov.  28, 2019, issue of The New England Journal of Medicine and presented earlier at the European Congress of Radiology (ECR) 2019.

Related Breast MRI and Dense Breast Content:

Breast Density Explained

Animation to Bring Clarity to Dense Breasts

Improving Clinical Image Quality for Breast Imaging

Breast Imaging in the Age of Coronavirus

Abbreviated MRI Outperforms 3-D Mammograms at Finding Cancer in Dense Breasts

VIDEO: Explaining Dense Breasts — Interview with Christiane Kuhl, M.D.

Technologies to Watch in Breast Imaging

Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
 

Reference:

Bakker MF, de Lange SV, Pijnappel RM, et al. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. N Engl J Med 2019; 381:2091-2102. DOI: 10.1056/NEJMoa1903986.

At the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, Rasu Shrestha, M.D., MBA, chief strategy officer for Atrium Health, discusses his new role with Atrium, the hype cycle of artificial intelligence (AI) and the key elements of getting AI in radiology — and in healthcare — right.

Read the article "Atrium Health Debuts Amazon Alexa Skill to Help Patients Access Medical Care"

Listen to the podcast Is Artificial Intelligence The Doom of Radiology?, a discussion with Shrestha.

Deborah Levine, M.D., professor of radiology at Harvard Medical School and vice chair for academic affairs in the Department of Radiology at Beth Israel Deaconess Medical Center, Boston, describes scenarios where magnetic resonance imaging (MRI) could be more useful than ultrasound in issues with the female pelvis.

At RSNA 2018, iCad showed how its ProFound AI for digital breast tomosynthesis technology might help in the interpretation of tomosynthesis exams. Rodney Hawkins, vice president of marketing for iCad, discusses how this technology can better help detect the cancer.

Related content:

Artificial Intelligence 2018: What Radiologists Need to Know About AI

RSNA 2018 Sunday – Improving, Not Replacing

ITN Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displayed on the expo floor at the 2018 Radiological Society of North America (RSNA) meeting. The video includes new technologies for fetal ultrasound, CT, MRI, mobile DR X-ray, a new generation of fluoroscopy systems, MRI contrast mapping to better identify tumors, and a new technique to create moving X-ray images from standard DR imaging.

Watch the related VIDEO: Editor’s Choice of the Most Innovative New Artificial Intelligence Technologies at RSNA 2018. This includes a tour of some of the recently FDA-cleared AI technologies for medical imaging at RSNA 2018. 

Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiologist, Elizabeth Wende Breast Care, explains the details of a new study showing the benefits of mammography in elderly women at the Radiological Society of North America (RSNA) 2018 annual meeting.

Elizabeth Chabner-Thompson, M.D., MPH, radiation oncologist, Northern Westchester Hospital, Northwell Health, Mt. Kisco, N.Y., and CEO of Masthead, explains an FDA-cleared bra she designed for improved patient positioning of women undergoing radiation therapy. She spoke to ITN at the 2018 ASTRO conference. 

ITN Editorial Director Melinda Taschetta-Millane speaks to DenseBreast-info Executive Director JoAnn Pushkin as the website celebrates three years as an information resource on breast density for patients and providers. Pushkin also discusses the latest developments in breast density notification and screening guidelines.

Related Dense Breast Imaging Content: 

VIDEO: The Impact of Breast Density Technology and Legislation

High-Risk Clinic Arms Patients Against Breast Cancer

Greater Evidence, Payment Expansion Driving Tomosynthesis Adoption

Technology to Watch in Breast Imaging

The Transition to 3-D Breast Imaging

Nancy M. Cappello, Ph.D., executive director and founder, Are You Dense Inc. and Are You Dense Advocacy. Read the article “The Evolution of Breast Imaging Technology.” Watch the VIDEO “Implementing Advanced Breast Imaging Technology.” 

Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre, and professor of medical biophysics and medical imaging, University of Toronto, discusses how contrast-enhanced mammography can improve breast cancer detection at the 2017 Radiological Society of North America (RSNA) meeting.

Watch the VIDEO “What is New in Breast Imaging Technology,” with Stamatia Destounis, M.D.

Watch the VIDEO "Implementing Advanced Breast Imaging Technology," with Gerry Kolb, JD.

William Hall, M.D., radiation oncologist in the Department of Radiation Oncology at PeaceHealth St. Joseph Medical Center in Bellingham, Wash., discusses study results presented at theAmerican Society of Radiation Oncology (ASTRO) 2016. Video courtesy of Dr. Hall. You can read Dr. Hall's article on this topic, Breast Cancer Radiation Planning, here. 

Monica Saini, M.D., consultant medical director — ABUS at GE Healthcare, discusses the necessity for personalized breast care, and how Automated Breast Ultrasound (ABUS) helps meet the challenges of screening and diagnostic imaging of dense breast tissue. To learn more about Automated Breast Ultrasound, please visit gehealthcare.com/inveniaabus.

The purpose of this exploratory video roundtable is to examine the state of breast biopsies today and to communicate the current challenges and inefficiencies affecting personnel that perform these important procedures. The video roundtable posed key questions to Key Opinion Leaders from the Cleveland Clinic on obstacles they face when performing stereotactic-guided breast biopsies, and why it is necessary to consider the ramifications. The roundtable discussion was hosted by Imaging Technology News and was funded through a grant from Hologic Inc.

Also, see the related article, Room for Improvement in Women's Health, by Laura Shepardson, M.D.

Ernie Bodai, M.D., vice president, National Consortium of Breast Centers (NCBC), discusses breast density with itnTV. Read an article with related links about breast density.

Jennifer Gass, M.D., FACS, president, National Consortium of Breast Centers (NCBC), discusses the state of the breast imaging industry.